June 2021

After PD-1 Inhibitor Indications Are Withdrawn in SCLC, What Now?

May 26, 2021

Martin J. Edelman, MD, chair of the Department of Hematology/Oncology and associate director for Translational Research at the Fox Chase Cancer Center in Philadelphia, Pennsylvania, discusses the the nuances of rescinded indications in small-cell lung cancer.